Illumina, ResMed drops; Broadridge, Rise of Humana

Placeholder while loading article actions

NEW YORK – Stocks that traded heavily or experienced significant price changes on Friday:

Illumina Inc., down $19.12 to $208.33.

The genetic testing tools company reported disappointing second-quarter financial results.

Chevron Corp., up 23 cents at $159.85.

Energy companies lagged the broader market as crude oil prices fell.

Freeport-McMoRan Inc., down 5 cents at $31.62.

The copper mining company fell along with base metal prices.

ResMed Inc., down 86 cents to $239.99.

The maker of medical products for respiratory disorders warned investors of ongoing supply chain issues.

Broadridge Financial Solutions Inc., up $13.49 to $183.22.

The tech outsourcing company beat Wall Street’s fiscal fourth quarter financial results.

Johnson & Johnson, down $1.84 to $165.30.

The Band-Aid maker will stop selling baby powder containing talc next year amid lawsuits claiming it caused cancer.

Humana Inc., up $12.81 at $496.88.

The health insurer buys most of the assets of Inclusa, a provider of long-term care services for the elderly in Wisconsin.

Newmont Corp., up $1.25 at $46.55.

The gold producer rose as prices for the precious metal rose slightly.


Comments are closed.